back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-01-08 Tx date 1996-06-07 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2018-01-08 Tx date 1996-07-25 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-08 Tx date 1996-06-07 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Warrants
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2018-01-08 Tx date 1996-07-25 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-08 Tx date 1996-06-07 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-01-08 Tx date 1996-07-25 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-08 Tx date 1996-06-07 |
$RX
Hedley Technologies Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
65,000 | ||
| Filed 2018-01-08 Tx date 1996-07-25 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-04 Tx date 2017-12-01 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,400
-800 vol $10.50 each |
277,900 | |
| Filed 2017-09-18 Tx date 2017-09-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,025
-1,300 vol $9.25 each |
16,621 | |
| Filed 2017-09-15 Tx date 2017-09-15 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,850
-200 vol $9.25 each |
17,921 | |
| Filed 2017-09-15 Tx date 2017-09-14 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,800
-1,500 vol $9.20 each |
18,121 | |
| Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
19,621 | |
| Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
||
| Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
||
| Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
||
| Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
||
| Filed 2017-08-21 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
18,393 | |
| Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$8,937
+993 vol $9.00 each |
1,362 | |
| Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$11,052
+1,228 vol $9.00 each |
3,818 | |
| Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$7,613
+1,228 vol $6.20 each |
2,590 | |
| Filed 2017-08-18 Tx date 2017-08-18 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,418
+993 vol $4.45 each |
369 | |
| Filed 2017-06-21 Tx date 2017-06-21 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-1,000 vol $8.10 each |
278,700 | |
| Filed 2017-06-21 Tx date 2017-06-21 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,830
-600 vol $8.05 each |
279,700 | |
| Filed 2017-06-20 Tx date 2017-06-19 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-805.00
-100 vol $8.05 each |
280,300 | |
| Filed 2017-06-14 Tx date 2017-06-12 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,610
-200 vol $8.05 each |
280,400 | |
| Filed 2017-03-31 Tx date 2017-03-31 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,975
-900 vol $7.75 each |
280,600 | |
| Filed 2017-03-24 Tx date 2017-03-20 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
10 - Acquisition or disposition in the public market
|
$-775.00
-100 vol $7.75 each |
-624 | |
| Filed 2017-03-20 Tx date 2017-03-17 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$29,640
+3,900 vol $7.60 each |
17,400 | |
| Filed 2017-03-20 Tx date 2017-03-17 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
11 - Acquisition or disposition carried out privately
|
$29,640
+3,900 vol $7.60 each |
-524 | |
| Filed 2017-03-20 Tx date 2017-03-17 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$354,900
+3,900 vol $91.00 each |
-4,424 | |
| Filed 2016-12-29 Tx date 2016-12-29 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,610
-200 vol $8.05 each |
281,500 | |
| Filed 2016-12-29 Tx date 2016-12-28 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,610
-200 vol $8.05 each |
281,700 | |
| Filed 2016-11-25 Tx date 2016-11-25 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,855
-1,100 vol $8.05 each |
281,900 | |
| Filed 2016-11-25 Tx date 2016-11-25 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,000
-2,000 vol $8.00 each |
283,000 | |
| Filed 2016-09-08 Tx date 2016-09-08 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,680
-800 vol $8.35 each |
13,500 | |
| Filed 2016-06-10 Tx date 2016-06-10 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,500
-1,000 vol $7.50 each |
14,300 | |
| Filed 2016-06-09 Tx date 2016-06-08 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,750
-1,700 vol $7.50 each |
15,300 | |
| Filed 2016-02-18 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,613
+1,228 vol $6.20 each |
-8,324 | |
| Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
| Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-4,400
-40,000 vol $0.11 each |
-9,552 | |
| Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
| Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
| Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
| Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
| Filed 2016-01-15 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
||
| Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
70,448 | |
| Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
150,448 | |
| Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$4,400
+40,000 vol $0.11 each |
110,448 | |
| Filed 2016-01-14 Tx date 2016-01-13 |
$RX
BioSyent Inc. |
Larson, Douglas Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$252,000
+40,000 vol $6.30 each |
285,000 |